Shattuck Labs
STTK | NASDAQ
$4.66
+$0.01 (+0.22%)
At close: Nov 16, 2026, 4:00 PM ET
$4.66
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
+0.22%
(1D)No price chart data available for 1D timeframe.
Rating
37.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #599/1021 (Top 59%)
Key Statistics
Market Data
Market Cap $853.83M
1D Range
4.52 4.81
52W Range
1.93 8.06
Valuation (TTM)
PE -9.14
PB 4.41
EV/EBITDA -9.86
Valuation (NTM)
Forward PE N/A
Forward PEG 0.26
Price Target $16.00
Cash Flow
FCF Yield -5.8%
SBC Adj. FCF Yield -7.0%
SBC Impact -20.2%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -129.8% |
-78.0%
Dil EPS 3Y | 5Y 50.0% |
24.8%
FCF 3Y | 5Y 12.0% |
20.4%
Returns
ROA -32.6%
ROE -46.5%
ROIC -36.8%
Financial Health
Net Cash
$196.31M
Current Ratio 15.80
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat b...
Sector Healthcare
Industry Biotechnology
Employees 40
IPO Date Oct 9, 2020
Website www.shattucklabs.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$16.00
Upside
+243.35%
Buy (4)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove STTK